KALA BIO, INC. Nontrade Receivables, Current
KALA BIO, INC. (KALA) had Nontrade Receivables, Current of $8.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:NontradeReceivablesCurrent · last filed 2025-11-19
- 2025-09-30: Nontrade Receivables, Current $8.00K.
- 2025-06-30: Nontrade Receivables, Current $15.00K.
- 2025-03-31: Nontrade Receivables, Current $99.00K.
- 2024-12-31: Nontrade Receivables, Current $99.00K.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2025-09-30 | $8.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $15.00K 10-Q · filed 2025-08-08 |
| 2025-03-31 | $99.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $99.00K 10-Q · filed 2025-11-19 |
| 2024-06-30 | $99.00K 10-Q · filed 2024-08-06 |
| 2023-12-31 | $119.00K 10-Q · filed 2024-08-06 |
| 2023-09-30 | $143.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $177.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $280.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $908.00K 10-K · filed 2024-03-29 |
| 2021-12-31 | $2.11M 10-K · filed 2022-03-29 |
| 2020-12-31 | $250.00K 10-K · filed 2022-03-29 |
| 2019-12-31 | $1.53M 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |